Zhengshi Lin

First Affiliated Hospital of Guangzhou Medical University — China

Medicine · Health Sciences

18h-index1.2kcitations42works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(14), Respiratory viral infections research(14), SARS-CoV-2 and COVID-19 Research(7), Retinal Development and Disorders(6), SARS-CoV-2 detection and testing(5)

Publications42 total

Cathepsin S contributes to influenza-induced lung injury by driving inflammation, promoting apoptosis, and disrupting epithelial barrier integrity
Microbiology Spectrum·2025Open Access
Efficacy and safety of onradivir in adults with acute uncomplicated influenza A infection in China: a multicentre, double-blind, randomised, placebo-controlled and oseltamivir-controlled, phase 3 trial
The Lancet Respiratory Medicine·2025· 9 cited
Application of novel dark-quencher labeled probes in multiplex qRT-PCR assays for rapid detection of SARS-CoV-2 variants
Journal of Thoracic Disease·2025Open Access
Pathogenesis of influenza and SARS-CoV-2 co-infection at the extremes of age: decipher the ominous tales of immune vulnerability
Advanced Biotechnology·2025· 8 citedOpen Access
Molecular epidemiology and phylogenetic analysis of influenza viruses A (H3N2) and B/Victoria during the COVID-19 pandemic in Guangdong, China
Infectious Diseases of Poverty·2024· 8 citedOpen Access
Modified transport medium for improving influenza virus detection
Frontiers in Cellular and Infection Microbiology·2024Open Access
Seroprevalence of Avian Influenza A(H5N6) Virus Infection, Guangdong Province, China, 2022
Emerging infectious diseases·2024· 4 citedOpen Access
Correction: Effect of YuPingFeng granules on clinical symptoms of stable COPD: study protocol for a multicenter, double-blind, and randomized controlled trial
BMC Complementary Medicine and Therapies·2024· 1 citedOpen Access
Safety and efficacy of onradivir in adults with acute uncomplicated influenza A infection: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
The Lancet Infectious Diseases·2024· 26 cited
Effect of YuPingFeng granules on clinical symptoms of stable COPD: study protocol for a multicenter, double-blind, and randomized controlled trial
BMC Complementary Medicine and Therapies·2024· 4 citedOpen Access
Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trial
EClinicalMedicine·2023· 38 citedOpen Access
Baloxavir marboxil use for critical human infection of avian influenza A H5N6 virus
Med·2023· 23 citedOpen Access
Severe pneumonia and pathogenic damage in human airway epithelium caused by Coxsackievirus B4
Emerging Microbes & Infections·2023· 8 citedOpen Access
Baloxavir marboxil use for critical human infection of avian influenza A H5N6 virus
2023· 4 citedOpen Access
Coinfection with influenza virus and non-typeable Haemophilus influenzae aggregates inflammatory lung injury and alters gut microbiota in COPD mice
Frontiers in Microbiology·2023· 13 citedOpen Access
Severe pneumonia and pathogenic damage in human airway epithelium caused by Coxsackievirus B4
Figshare·2023Open Access
How fast and how well the Omicron epidemic was curtailed. A Guangzhou experience to share
Frontiers in Public Health·2022· 4 citedOpen Access
Containment of SARS-CoV-2 Delta strain in Guangzhou, China by quarantine and social distancing: a modelling study
Scientific Reports·2022· 5 citedOpen Access
Culturing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Diagnosis and Genome Sequencing
Laboratory Medicine·2022· 2 citedOpen Access
Different Circulation Pattern of Multiple Respiratory Viruses in Southern China During the COVID-19 Pandemic
Frontiers in Microbiology·2022· 22 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Zifeng Yang(15), Yangqing Zhan(8), Jingyi Liang(8), Zhiqi Zeng(7), Hang Xie(7), Wenda Guan(7), Kailin Mai(7), Nanshan Zhong(6), Chuanmeizi Tu(6), Rong Zhou(5), Zhiping Ye(5), Stephen Yazulla(5), Weiqi Pan(5), Jinchao Zhou(5), Xiao Y. Wu(5), Chunguang Yang(5), Chitin Hon(5), Dehui Chen(4), Shuyan Qiu(4), Duo Xu(4)